| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 2.72e-05 | 18 | 66 | 3 | GO:0015347 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 1.07e-04 | 5 | 66 | 2 | GO:0008294 | |
| Domain | GPCR_Rhodpsn_7TM | OR2T3 GPR31 GPR37 OR9I1 P2RY10 OR2T1 P2RY14 OR2T34 LGR5 OR4F6 | 9.94e-05 | 670 | 65 | 10 | IPR017452 |
| Domain | 7tm_1 | OR2T3 GPR31 GPR37 OR9I1 P2RY10 OR2T1 P2RY14 OR2T34 LGR5 OR4F6 | 1.08e-04 | 677 | 65 | 10 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR2T3 GPR31 GPR37 OR9I1 P2RY10 OR2T1 P2RY14 OR2T34 LGR5 OR4F6 | 1.19e-04 | 685 | 65 | 10 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR2T3 GPR31 GPR37 OR9I1 P2RY10 OR2T1 P2RY14 OR2T34 LGR5 OR4F6 | 1.28e-04 | 691 | 65 | 10 | PS50262 |
| Domain | GPCR_Rhodpsn | OR2T3 GPR31 GPR37 OR9I1 P2RY10 OR2T1 P2RY14 OR2T34 LGR5 OR4F6 | 1.30e-04 | 692 | 65 | 10 | IPR000276 |
| Domain | AC_N | 3.29e-04 | 8 | 65 | 2 | IPR032628 | |
| Domain | Adcy | 3.29e-04 | 8 | 65 | 2 | IPR030672 | |
| Domain | AC_N | 3.29e-04 | 8 | 65 | 2 | PF16214 | |
| Domain | LRRNT | 3.78e-04 | 98 | 65 | 4 | IPR000372 | |
| Domain | LRRNT | 3.78e-04 | 98 | 65 | 4 | SM00013 | |
| Domain | KAZAL_2 | 7.02e-04 | 50 | 65 | 3 | PS51465 | |
| Domain | Kazal_dom | 7.44e-04 | 51 | 65 | 3 | IPR002350 | |
| Domain | OA_transporter | 7.70e-04 | 12 | 65 | 2 | IPR004156 | |
| Domain | OATP | 7.70e-04 | 12 | 65 | 2 | PF03137 | |
| Domain | A/G_cyclase_CS | 1.57e-03 | 17 | 65 | 2 | IPR018297 | |
| Domain | Nucleotide_cyclase | 1.76e-03 | 18 | 65 | 2 | IPR029787 | |
| Domain | - | 1.76e-03 | 18 | 65 | 2 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_1 | 1.96e-03 | 19 | 65 | 2 | PS00452 | |
| Domain | Guanylate_cyc | 1.96e-03 | 19 | 65 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 1.96e-03 | 19 | 65 | 2 | PS50125 | |
| Domain | A/G_cyclase | 1.96e-03 | 19 | 65 | 2 | IPR001054 | |
| Domain | CYCc | 1.96e-03 | 19 | 65 | 2 | SM00044 | |
| Domain | LRR_8 | 2.97e-03 | 171 | 65 | 4 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 3.37e-03 | 177 | 65 | 4 | IPR003591 | |
| Domain | LRR_TYP | 3.37e-03 | 177 | 65 | 4 | SM00369 | |
| Domain | MFS | 6.33e-03 | 108 | 65 | 3 | PS50850 | |
| Domain | Kazal_2 | 6.96e-03 | 36 | 65 | 2 | PF07648 | |
| Domain | LRR_1 | 7.13e-03 | 219 | 65 | 4 | PF00560 | |
| Domain | Cadherin_tail | 7.34e-03 | 37 | 65 | 2 | PF15974 | |
| Domain | Cadherin_CBD | 7.34e-03 | 37 | 65 | 2 | IPR031904 | |
| Domain | Cadherin_C | 9.39e-03 | 42 | 65 | 2 | IPR032455 | |
| Domain | Cadherin_C_2 | 9.39e-03 | 42 | 65 | 2 | PF16492 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 29784826 | ||
| Pubmed | Leucine-rich repeat transmembrane proteins are essential for maintenance of long-term potentiation. | 3.77e-06 | 2 | 68 | 2 | 23931994 | |
| Pubmed | PKCη is a negative regulator of AKT inhibiting the IGF-I induced proliferation. | 3.77e-06 | 2 | 68 | 2 | 22305966 | |
| Pubmed | Nuclear calcium signaling induces expression of the synaptic organizers Lrrtm1 and Lrrtm2. | 3.77e-06 | 2 | 68 | 2 | 25527504 | |
| Pubmed | Distinct but overlapping roles of LRRTM1 and LRRTM2 in developing and mature hippocampal circuits. | 3.77e-06 | 2 | 68 | 2 | 35662394 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 29783855 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 16598383 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 27791005 | ||
| Pubmed | Proteomic Analysis of Unbounded Cellular Compartments: Synaptic Clefts. | 2.25e-05 | 4 | 68 | 2 | 27565350 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 16860615 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 21788371 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 21708131 | ||
| Pubmed | HERC2 Interacts with Claspin and regulates DNA origin firing and replication fork progression. | 2.25e-05 | 4 | 68 | 2 | 21775519 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 22503545 | ||
| Pubmed | Mammalian adenylyl cyclase family members are randomly located on different chromosomes. | 3.75e-05 | 5 | 68 | 2 | 7959689 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 12676565 | ||
| Pubmed | Mapping of adenylyl cyclase genes type I, II, III, IV, V, and VI in mouse. | 5.62e-05 | 6 | 68 | 2 | 7766992 | |
| Pubmed | Expression and regulation of adenylyl cyclase isoforms in the human adrenal gland. | 5.62e-05 | 6 | 68 | 2 | 11549699 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 12613887 | ||
| Pubmed | TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis. | 1.05e-04 | 8 | 68 | 2 | 29443964 | |
| Pubmed | Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. | 1.34e-04 | 9 | 68 | 2 | 9417641 | |
| Pubmed | 1.34e-04 | 9 | 68 | 2 | 12503609 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 1.34e-04 | 9 | 68 | 2 | 17229090 | |
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 1.68e-04 | 10 | 68 | 2 | 8663304 | |
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 16615126 | ||
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 1.68e-04 | 10 | 68 | 2 | 11884542 | |
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 11299302 | ||
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 10089566 | ||
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 10808179 | ||
| Pubmed | 2.45e-04 | 12 | 68 | 2 | 10807185 | ||
| Pubmed | A genome-wide association study for reading and language abilities in two population cohorts. | 2.90e-04 | 13 | 68 | 2 | 23738518 | |
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 3.38e-04 | 14 | 68 | 2 | 14993377 | |
| Pubmed | A neurogenomics approach to gene expression analysis in the developing brain. | 3.52e-04 | 170 | 68 | 4 | 15582152 | |
| Pubmed | 3.89e-04 | 15 | 68 | 2 | 7937899 | ||
| Pubmed | cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. | 3.89e-04 | 15 | 68 | 2 | 2165385 | |
| Pubmed | 3.89e-04 | 15 | 68 | 2 | 23515096 | ||
| Pubmed | 4.44e-04 | 16 | 68 | 2 | 17567809 | ||
| Pubmed | Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. | 4.44e-04 | 16 | 68 | 2 | 19679677 | |
| Pubmed | 4.83e-04 | 331 | 68 | 5 | 20634891 | ||
| Pubmed | 5.03e-04 | 17 | 68 | 2 | 16214126 | ||
| Pubmed | 5.65e-04 | 18 | 68 | 2 | 22446963 | ||
| Pubmed | 6.30e-04 | 19 | 68 | 2 | 34359856 | ||
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 8.70e-04 | 95 | 68 | 3 | 29643511 | |
| Pubmed | 9.28e-04 | 23 | 68 | 2 | 29981310 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 1.07e-03 | 1061 | 68 | 8 | 33845483 | |
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 1.19e-03 | 26 | 68 | 2 | 34848499 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 1.38e-03 | 28 | 68 | 2 | 15347688 | |
| Pubmed | Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. | 1.48e-03 | 29 | 68 | 2 | 22956684 | |
| Pubmed | TRIM28 modulates nuclear receptor signaling to regulate uterine function. | 1.58e-03 | 30 | 68 | 2 | 37528140 | |
| Pubmed | 1.69e-03 | 31 | 68 | 2 | 12626323 | ||
| Cytoband | 1q44 | 5.99e-04 | 110 | 68 | 3 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 9.29e-04 | 128 | 68 | 3 | chr1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q31 | 1.20e-03 | 140 | 68 | 3 | chr7q31 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.69e-04 | 10 | 45 | 2 | 53 | |
| GeneFamily | Purinergic receptors P2Y | 2.69e-04 | 10 | 45 | 2 | 213 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 9.62e-04 | 78 | 45 | 3 | 262 | |
| GeneFamily | Olfactory receptors, family 2 | 2.79e-03 | 113 | 45 | 3 | 149 | |
| GeneFamily | Solute carriers | 2.89e-03 | 395 | 45 | 5 | 752 | |
| Coexpression | GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP | 7.21e-07 | 200 | 66 | 7 | M6832 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.58e-06 | 154 | 67 | 5 | 71d33b5dbfab5820e3daddb01806a69116ba8008 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.45e-06 | 161 | 67 | 5 | 78cc5bc488bc47726195a649946d414e6bfabf94 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.59e-06 | 162 | 67 | 5 | 0fa93efc9c005d1e649b3f7069ae8641d6e41ed8 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.97e-06 | 171 | 67 | 5 | 3d60e7ecf25e4b781ba2387671b2aad247fb75ff | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-06 | 173 | 67 | 5 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-06 | 173 | 67 | 5 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.50e-06 | 174 | 67 | 5 | 991f7eab69ea3ee1045a4e44ce60a96db13df6d1 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.50e-06 | 174 | 67 | 5 | c8cec89369cf3896c5626e447051e76a142cb6df | |
| ToppCell | Control-Myeloid-DC1|Myeloid / Condition, Lineage and Cell class | 8.52e-06 | 184 | 67 | 5 | b5c1f57f0356969cfb0e1dac764684fc5583bc04 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.45e-06 | 188 | 67 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.45e-06 | 188 | 67 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.45e-06 | 188 | 67 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Mild-Myeloid-mDC|Mild / Condition, Lineage, Cell class and cell subclass | 1.05e-05 | 192 | 67 | 5 | da3952bd5c96242c15eb76678d0608ae2926a16e | |
| ToppCell | Mild-Myeloid-mDC-|Mild / Condition, Lineage, Cell class and cell subclass | 1.05e-05 | 192 | 67 | 5 | 8520b3fdf4508ac66f7918da613abc928ab5832a | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 162 | 67 | 4 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 162 | 67 | 4 | ca1014e32996f777bff021830ce9a7cf4acf58d5 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 166 | 67 | 4 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 168 | 67 | 4 | 0e8b0e6399c6c82c9c0e546f7316f902de0765d3 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.22e-04 | 169 | 67 | 4 | a4204bdd75837f5fee9aaac459cb4c19ee2a7bf4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 169 | 67 | 4 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.22e-04 | 169 | 67 | 4 | e3410ccb3f85811c75694e286115803911169a2f | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-04 | 169 | 67 | 4 | a4f610d07c3ba5537f4497f523669b914f7eddc1 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-04 | 170 | 67 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 171 | 67 | 4 | 6f49537f8d3cf18e65aa999fec32ed347ce2da3e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 171 | 67 | 4 | ab97ae2b127a585f170f028f1c475cdd1b0cdea5 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 172 | 67 | 4 | b043d4f81dced7fb3326043f68474123be47cc5d | |
| ToppCell | LV-17._Lymphocyte|World / Chamber and Cluster_Paper | 1.34e-04 | 173 | 67 | 4 | 212f013ff761cbab24a537071739867c08c402a4 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 174 | 67 | 4 | 7be0c6248e77f2d0260b852b01e17892f7828f1b | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.37e-04 | 174 | 67 | 4 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-04 | 175 | 67 | 4 | 1b910c08d2bfbcc77431ee66103e63a11a9d39fe | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-04 | 176 | 67 | 4 | dca70f309af24421f8dc708cbd88512814b8e79e | |
| ToppCell | Int-URO-Lymphocyte-T_NK-gdT|Int-URO / Disease, Lineage and Cell Type | 1.43e-04 | 176 | 67 | 4 | 15016a73c953d8d3e7c32a05ead5e7261f9914ca | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 177 | 67 | 4 | d445167dae956e641386f84ab3ae9f47c089e09a | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-04 | 178 | 67 | 4 | c4a2e9a440e941e82bb35abefa054e07ad250d45 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 178 | 67 | 4 | 0b456ac768e026c3ecd5a9a4f43d6f126e7685a1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 178 | 67 | 4 | 7467e5ab2fcb39cc4a2c7dd69722c91def3b6aea | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.56e-04 | 180 | 67 | 4 | 32d871738a24071b70084a7e80148a516110c78b | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.56e-04 | 180 | 67 | 4 | 067ca8a15228c7f3b3bc7aecbc9b1611ca05e176 | |
| ToppCell | Severe-Myeloid-mDC|Severe / Condition, Lineage, Cell class and cell subclass | 1.59e-04 | 181 | 67 | 4 | 00f2949b609ac21bd2da6fd8f685739eeb2f48ad | |
| ToppCell | Severe-Myeloid-mDC-|Severe / Condition, Lineage, Cell class and cell subclass | 1.59e-04 | 181 | 67 | 4 | 51ded98c76ec35ab1d24ac3ab98280381daa9831 | |
| ToppCell | Control-Myeloid-DC1|Control / Condition, Lineage and Cell class | 1.59e-04 | 181 | 67 | 4 | 5a2a1f017ad23baed9972c68b4a46f4c618ef21a | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC1|Lung / Manually curated celltypes from each tissue | 1.66e-04 | 183 | 67 | 4 | e4cbd39575b5a4612d9934532e3bad63286f8aa5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 184 | 67 | 4 | 73eaac74a88bf5fd23d88035fac398ac43b268c5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Endo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 184 | 67 | 4 | 65f651d4b93ed0b52f526d3f517d92b6c62aaec3 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell-4|TCGA-Uvea / Sample_Type by Project: Shred V9 | 1.70e-04 | 184 | 67 | 4 | 9c56753e5e668be888662e4713cf4ce44e6c58fb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 184 | 67 | 4 | 9001d35cdde061d06f8545b3cee942d1299129db | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 184 | 67 | 4 | f4344f3c407b2d4d703fe56e43d84dbfe60ba833 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-04 | 185 | 67 | 4 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 187 | 67 | 4 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.84e-04 | 188 | 67 | 4 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-04 | 188 | 67 | 4 | c39083b8020ae507246959abbb299d78bcd14042 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-04 | 188 | 67 | 4 | 6e7a678474715f035cc13a0e226a937688f54121 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-04 | 188 | 67 | 4 | 8862ecb87fc9b95eccc527387f2332dcc92cfdc3 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.96e-04 | 191 | 67 | 4 | de25b2a4b5daadb05a54b1262557398da6314e7f | |
| ToppCell | (1)_T_CD4_fh|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.96e-04 | 191 | 67 | 4 | 66ddff9a99092cb384b9fb2a3ba95ddbebed67cc | |
| ToppCell | COVID-19-Myeloid-DC1|Myeloid / Condition, Lineage and Cell class | 1.96e-04 | 191 | 67 | 4 | 4be3c6287965fe3a2f109d26f68bdc2fa393f99b | |
| ToppCell | (3)_MNP-(3)_DC_1|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.96e-04 | 191 | 67 | 4 | cf0ea54670ed478c3302ccfbee9f6b6706e49fcd | |
| ToppCell | VE-mDC1-|VE / Condition, Cell_class and T cell subcluster | 2.04e-04 | 193 | 67 | 4 | 5df6033bc0e4f96a20d526486a8e89c990e21831 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.04e-04 | 193 | 67 | 4 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | VE-mDC1|VE / Condition, Cell_class and T cell subcluster | 2.04e-04 | 193 | 67 | 4 | 12b2708db9db8b88365b8ebeb4908f28c50081bb | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 194 | 67 | 4 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 194 | 67 | 4 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.08e-04 | 194 | 67 | 4 | bf2480acec5612cd8a3c33d3e7a98176dc6c9091 | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 194 | 67 | 4 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | BAL-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.12e-04 | 195 | 67 | 4 | 6ba23e19801305e071b0e4aaf1ee6f53f3b027d3 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.12e-04 | 195 | 67 | 4 | 66e5fd9f3208a06d617c5e994822bf57dceae7e2 | |
| ToppCell | mild_COVID-19-CD4+_CTL|World / disease group, cell group and cell class (v2) | 2.12e-04 | 195 | 67 | 4 | 980909246c30471c9f2f97c3b20b6d6d20fe574e | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.12e-04 | 195 | 67 | 4 | 7209babdff96c93cd52cfe5d5cfd7e3c0274d8dd | |
| ToppCell | BAL-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.12e-04 | 195 | 67 | 4 | 9e5cf33b5dd455efa464a63d7116786c0786aefd | |
| ToppCell | Mild_COVID-19-Myeloid-cDC|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.12e-04 | 195 | 67 | 4 | 24149bb6933135b1a0a5c7f505914942b3782c3a | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.16e-04 | 196 | 67 | 4 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.20e-04 | 197 | 67 | 4 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 197 | 67 | 4 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | distal-mesenchymal-Lipofibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.20e-04 | 197 | 67 | 4 | 865010edcd7e3f79f505fcef7b33882095994aa8 | |
| ToppCell | distal-mesenchymal-Lipofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.20e-04 | 197 | 67 | 4 | ceb83bdef16b58ee16193413bfb006f7715728b2 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-04 | 197 | 67 | 4 | 131bc6ef55f467cc802db68daf7e7d757ea64fc6 | |
| ToppCell | ASK452-Epithelial-Type_1|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.20e-04 | 197 | 67 | 4 | dc0a6dca4af6b216357b06f67203274f8b2a8bb0 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_CTL|Influenza_Severe / Disease, condition lineage and cell class | 2.20e-04 | 197 | 67 | 4 | 8610307434d99e6411a5a6c6769094e9a0749d4d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-04 | 197 | 67 | 4 | d6eb843f5ee1b1ea54416ba6e987eefe86ca3216 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.20e-04 | 197 | 67 | 4 | 112fa8afa1ced08741d76185d48a914e6f32c8a8 | |
| ToppCell | Mild|World / Condition, Lineage, Cell class and cell subclass | 2.20e-04 | 197 | 67 | 4 | 476b0d0389f9fcd4614f6bb1f494281f467f6730 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-04 | 197 | 67 | 4 | 11762042f9ee8d02af432ccffe1c05aee9cb11ea | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 198 | 67 | 4 | 1378c6d4ceb84b42fdd6556be3296df7a8059e6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 198 | 67 | 4 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD4+_Tem|Bac-SEP / Disease, condition lineage and cell class | 2.25e-04 | 198 | 67 | 4 | 292b26f316f016b50d07689f84772eec46060251 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.25e-04 | 198 | 67 | 4 | 33a3b279c9ff3b762e52d060dae062167ca2239b | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.29e-04 | 199 | 67 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Capillary|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.33e-04 | 200 | 67 | 4 | 6c0498a5868891e8e22c03469d00669b20249b1a | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Capillary-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.33e-04 | 200 | 67 | 4 | 7020045b933cb104fb99b79524cb0d4734b8636d | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.33e-04 | 200 | 67 | 4 | 8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Capillary|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.33e-04 | 200 | 67 | 4 | e9913511a129bb3cee85e7ebf565b951dab91542 | |
| Disease | skin pigmentation measurement | 1.32e-05 | 137 | 65 | 5 | EFO_0007009 | |
| Disease | X-12844 measurement | 1.70e-04 | 9 | 65 | 2 | EFO_0021339 | |
| Disease | forced expiratory volume, body mass index | 2.59e-04 | 11 | 65 | 2 | EFO_0004314, EFO_0004340 | |
| Disease | alcohol consumption measurement, alcohol drinking | 3.11e-04 | 12 | 65 | 2 | EFO_0004329, EFO_0007878 | |
| Disease | IGF-1 measurement, IGFBP-3 measurement | 6.36e-04 | 17 | 65 | 2 | EFO_0004626, EFO_0004627 | |
| Disease | neutrophil measurement | 6.37e-04 | 177 | 65 | 4 | EFO_0803548 | |
| Disease | Chronic myeloproliferative disorder | 7.98e-04 | 19 | 65 | 2 | C1292778 | |
| Disease | androsterone glucuronide measurement | 8.85e-04 | 20 | 65 | 2 | EFO_0800317 | |
| Disease | Seckel syndrome | 1.07e-03 | 22 | 65 | 2 | C0265202 | |
| Disease | mental development measurement | 1.39e-03 | 25 | 65 | 2 | EFO_0008230 | |
| Disease | epiandrosterone sulfate measurement | 1.39e-03 | 25 | 65 | 2 | EFO_0021120 | |
| Disease | free androgen index | 1.41e-03 | 374 | 65 | 5 | EFO_0007005 | |
| Disease | Vitiligo | 1.46e-03 | 101 | 65 | 3 | EFO_0004208 | |
| Disease | arteriosclerosis (is_marker_for) | 1.87e-03 | 29 | 65 | 2 | DOID:2349 (is_marker_for) | |
| Disease | Drug habituation | 2.11e-03 | 115 | 65 | 3 | C0013170 | |
| Disease | Substance-Related Disorders | 2.11e-03 | 115 | 65 | 3 | C0236969 | |
| Disease | Drug abuse | 2.11e-03 | 115 | 65 | 3 | C0013146 | |
| Disease | Drug Use Disorders | 2.11e-03 | 115 | 65 | 3 | C0013222 | |
| Disease | Drug Dependence | 2.11e-03 | 115 | 65 | 3 | C1510472 | |
| Disease | Substance Dependence | 2.11e-03 | 115 | 65 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 2.11e-03 | 115 | 65 | 3 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.11e-03 | 115 | 65 | 3 | C0029231 | |
| Disease | Prescription Drug Abuse | 2.11e-03 | 115 | 65 | 3 | C4316881 | |
| Disease | Substance abuse problem | 2.17e-03 | 116 | 65 | 3 | C0740858 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TARLFSKKIFCCLFF | 216 | Q8N6Q1 | |
| CCLFFITLFFIRLLS | 226 | Q8N6Q1 | |
| NLLCPFCLKIFKTAT | 431 | Q86YH2 | |
| VFLLFLCFHLRFCKV | 6 | P05156 | |
| CLTQFCILFKRTFLS | 401 | P45844 | |
| LFPFGFICCFALRKR | 101 | O95415 | |
| CFICFIQLLIFPHST | 681 | O43306 | |
| FLPFELACQSKCPRI | 81 | Q9Y6D6 | |
| LCFGCKFQFKPIRVS | 226 | Q6P6C2 | |
| LVVVLFALCFLPCFL | 226 | O00270 | |
| FALCFLPCFLARVLM | 231 | O00270 | |
| LFIQKLRQCCVLFDF | 41 | Q13362 | |
| FLFGPCFFNLLIKCV | 471 | B6SEH9 | |
| FCTCLATVFSFLKRL | 11 | O00559 | |
| VLFLFLLSLFCPALC | 16 | Q9UN71 | |
| CKFLRFFFNPLHLCS | 116 | D6REC4 | |
| FFFCDLPPLLKLACS | 176 | Q8NGQ6 | |
| YFLNVFFPLLKVCCL | 6 | O43869 | |
| FIIFIVFISRKCCPP | 436 | O43300 | |
| KCFPASLRQLRQCFV | 451 | Q86UE6 | |
| FSNLELKFCFRISPC | 526 | Q86W26 | |
| LKFCFRISPCLAQDL | 531 | Q86W26 | |
| TCFFLLKLPRYSCKQ | 4761 | O95714 | |
| SFFCDLPRFIKLACI | 176 | Q8NGB9 | |
| IILIGCAFFFCCLPN | 161 | Q96FX8 | |
| LFIRKSFRPFKCLQC | 521 | Q9NQV6 | |
| SFRPFKCLQCGKAFR | 526 | Q9NQV6 | |
| FPFCQSRKILSFFCE | 171 | Q8NGX1 | |
| FPFCQSRKILSFFCE | 171 | Q8NH03 | |
| VLFLFLLSLFCPALC | 16 | Q9Y5G0 | |
| CFLFALTRQKLPPFC | 601 | Q8IWF2 | |
| FIKFACNQERIPFTC | 3911 | Q9Y4D8 | |
| LLKCKRDSFPNFLAC | 66 | P17568 | |
| LLALFFLPFCLCQDE | 11 | Q9BXJ4 | |
| PKRNCIFRHFCTLFQ | 71 | P0C7X3 | |
| ALLFSLTFALLCCPF | 126 | Q08828 | |
| PVLLFCLCKPFSRAF | 546 | O15354 | |
| CNLFCSLLFIIPKKL | 306 | Q9UG22 | |
| KPRGRNIFKALFCCF | 31 | O14595 | |
| LVQKKPLIFLGCCFF | 991 | Q86Z14 | |
| SLPTQLFKCCFCDFL | 6 | P05019 | |
| TFLLIPCCLTLNFRA | 26 | P38567 | |
| SCDFLPRFQCVFQVL | 576 | Q8WXE1 | |
| PRFQCVFQVLPKCLS | 581 | Q8WXE1 | |
| LRIPNICKRICFLSF | 341 | Q6T423 | |
| ICKRICFLSFVRFAS | 346 | Q6T423 | |
| LLAFFKCCLLTDQLP | 226 | O00411 | |
| LLFTNCILNCPVAFL | 771 | O75473 | |
| CISLQRCFFLLKPFR | 126 | O00398 | |
| FCFKSLKCPLLTAQF | 211 | Q92990 | |
| KDFCQFLLEIFPFLR | 276 | Q8NFB2 | |
| CKRTCNTLIPFLVFL | 641 | Q9H2Y9 | |
| KFPQLCKFCDVRFST | 46 | P37173 | |
| ISCLCPFYLIRLQLF | 261 | Q92535 | |
| FFLCQPFREILCKKL | 296 | Q15391 | |
| FFFVRCTPKDPICIA | 41 | Q14865 | |
| LAIALLFFFICVCRN | 416 | Q01973 | |
| ICPDCFRQHFTIALK | 721 | Q96EP0 | |
| QCFACPNCFLLFSRK | 251 | Q9Y4E5 | |
| FVLQYCKCLALEQPF | 716 | Q96HI0 | |
| KFLQLCIFPRCIFSA | 976 | Q8NI27 | |
| RQYPLFCFLLLCLSA | 26 | Q9Y5W7 | |
| CFSIFCVILRTQKPK | 536 | P50443 | |
| ETHCAKLPIFLCIFF | 571 | Q6ZQN7 | |
| LRLLQCAEPYKVSFC | 81 | Q9BXM0 | |
| KNPIAFACFFICLIT | 221 | Q9H0V1 | |
| LPIFRFYIKCTRCLA | 71 | Q9BW85 | |
| PLKLSVFFPIVFCIC | 421 | Q92536 | |
| IFIITKFCLFCFRKL | 506 | P54855 | |
| VLCFLLLLGFQFVCP | 11 | Q6ZMP0 | |
| FLQVIPCFQRDGLFC | 291 | Q9BZH6 | |
| LIFFCPLDLFYKCVC | 96 | Q9H6F2 | |
| LTQLFCCFQTPDRLF | 416 | P24723 | |
| NACIPLKRIAYFLCL | 11 | O95970 |